Valuation Bayer AG

Equities

Market Closed - Xetra Other stock markets 11:35:20 2024-12-03 am EST			5-day change	1st Jan Change
19.23 ^EUR	-0.27%		+1.79%	-42.81%

Dec. 03	BAYER AG : JP Morgan reaffirms its Neutral rating	ZD
Dec. 03	ZBD Pharma Gets China Approval for Antibacterial Injection	MT

Data adjusted to current consolidation scope

Fiscal Period: Diciembre	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	71,530	47,309	46,174	47,476	33,039	18,896	-	-
Change	-	-33.86%	-2.4%	2.82%	-30.41%	-42.81%	-	-
Enterprise Value (EV) ¹	105,598	84,884	79,140	78,749	67,302	51,206	48,099	44,722
Change	-	-19.62%	-6.77%	-0.49%	-14.54%	-23.92%	-6.07%	-7.02%
P/E ratio	17.5x	-4.51x	46.1x	11.5x	-11.2x	-695x	8.1x	6.61x
PBR	1.51x	1.55x	1.4x	1.22x	1x	0.57x	0.53x	0.49x
PEG	-	0x	-0x	0x	0x	7x	-0x	0.3x
Capitalization / Revenue	1.64x	1.14x	1.05x	0.94x	0.69x	0.41x	0.41x	0.4x
EV / Revenue	2.43x	2.05x	1.8x	1.55x	1.41x	1.1x	1.03x	0.94x
EV / EBITDA	9.18x	7.41x	7.08x	5.83x	5.75x	5.06x	4.93x	4.4x
EV / EBIT	15.1x	12x	10.8x	8.51x	8.87x	8.16x	8.16x	7.21x
EV / FCF	19x	34.2x	31.9x	19x	28.4x	18.6x	11.8x	10.6x
FCF Yield	5.26%	2.93%	3.13%	5.26%	3.52%	5.39%	8.5%	9.46%
Dividend per Share ²	2.8	2	2	2.4	0.11	0.1088	0.1088	1.089
Rate of return	3.85%	4.15%	4.26%	4.97%	0.33%	0.57%	0.57%	5.66%
EPS ²	4.17	-10.68	1.02	4.22	-2.99	-0.0277	2.375	2.908
Distribution rate	67.1%	-18.7%	196%	56.9%	-3.68%	-393%	4.58%	37.4%
Net sales ¹	43,545	41,400	44,081	50,739	47,637	46,410	46,620	47,437
EBITDA ¹	11,503	11,461	11,179	13,513	11,706	10,116	9,756	10,173
EBIT ¹	7,007	7,095	7,295	9,257	7,589	6,277	5,893	6,206
Net income ¹	4,091	-10,495	1,000	4,150	-2,941	-25.93	2,334	2,857
Net Debt ¹	34,068	37,575	32,966	31,273	34,263	32,310	29,203	25,826
Reference price ²	72.81	48.16	47.00	48.32	33.63	19.23	19.23	19.23
Nbr of stocks (in thousands)	982,424	982,424	982,424	982,424	982,424	982,424	-	-
Announcement Date	2/27/20	2/25/21	3/1/22	2/28/23	3/5/24	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
BAYER AG	-696.5x	1.1x	5.07x	+0.56%	19.88B
ELI LILLY AND COMPANY	62.64x	16.24x	45.97x	+0.65%	720B
NOVO NORDISK A/S	34.37x	12.03x	24.3x	+1.45%	483B
JOHNSON & JOHNSON	22.57x	4.33x	12.62x	+3.15%	373B
ABBVIE INC.	38.25x	6.76x	14.65x	+3.43%	321B
MERCK & CO., INC.	14.16x	4.33x	10.2x	+3.03%	255B
ROCHE HOLDING AG	15.46x	3.64x	9.51x	+3.84%	232B
NOVARTIS AG	19.13x	4.44x	11.2x	+3.59%	210B
ASTRAZENECA PLC	24.58x	4.31x	13.46x	+2.33%	207B
AMGEN INC.	30.78x	5.97x	10.38x	+3.26%	149B
Average	-43.46x	6.32x	15.74x	+2.53%	296.96B
Weighted average by Cap.	30.12x	8.75x	22.17x	+2.30%